Cumberland Pharmaceuticals/$CPIX
1D1W1MYTD1Y5YMAX
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
- Ticker
- $CPIX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 88
- Headquarters
- Nashville, United States
- Website
- www.cumberlandpharma.com
CPIX Metrics
BasicAdvanced
$130M
-
-$0.73
0.11
$1.50
17.34%
Price and volume
Market cap
$130M
Beta
0.11
52-week high
$9.28
52-week low
$1.85
Average daily volume
120K
Dividend rate
$1.50
Financial strength
Current ratio
0.956
Quick ratio
0.491
Long term debt to equity
24.617
Total debt to equity
27.558
Interest coverage (TTM)
-6.18%
Profitability
EBITDA (TTM)
1.097
Gross margin (TTM)
84.95%
Net profit margin (TTM)
-24.64%
Operating margin (TTM)
-6.87%
Effective tax rate (TTM)
-1.15%
Revenue per employee (TTM)
$500,000
Management effectiveness
Return on assets (TTM)
-2.91%
Return on equity (TTM)
-14.39%
Valuation
Price to revenue (TTM)
2.902
Price to book
7.43
Price to tangible book (TTM)
7.45
Price to free cash flow (TTM)
213.438
Free cash flow yield (TTM)
0.47%
Free cash flow per share (TTM)
0.041
Dividend yield (TTM)
17.34%
Growth
Revenue change (TTM)
5.31%
Earnings per share change (TTM)
265.45%
3-year revenue growth (CAGR)
2.91%
10-year revenue growth (CAGR)
3.61%
3-year earnings per share growth (CAGR)
80.99%
10-year earnings per share growth (CAGR)
54.08%
CPIX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.